Cargando…
circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson’s disease
Circular RNA (circRNA) is a type of non-coding RNA that is widely expressed in mammals. It is highly conserved and abundantly expressed in the brain. Here, we report the regulatory role of circRNA derived from the pantothenate kinase 1 (Pank1) gene (circ-Pank1) in Parkinson’s disease (PD). Circ-Pank...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120029/ https://www.ncbi.nlm.nih.gov/pubmed/35589691 http://dx.doi.org/10.1038/s41419-022-04934-2 |
_version_ | 1784710816760594432 |
---|---|
author | Liu, Qing Li, Qiyao Zhang, Runjiao Wang, Hongfang Li, Yibo Liu, Ziyu Xie, Wenmeng Geng, Dandan Wang, Lei |
author_facet | Liu, Qing Li, Qiyao Zhang, Runjiao Wang, Hongfang Li, Yibo Liu, Ziyu Xie, Wenmeng Geng, Dandan Wang, Lei |
author_sort | Liu, Qing |
collection | PubMed |
description | Circular RNA (circRNA) is a type of non-coding RNA that is widely expressed in mammals. It is highly conserved and abundantly expressed in the brain. Here, we report the regulatory role of circRNA derived from the pantothenate kinase 1 (Pank1) gene (circ-Pank1) in Parkinson’s disease (PD). Circ-Pank1 is highly expressed in the substantia nigra (SN) of PD model mice treated with rotenone and in the MN9D cell model of dopaminergic neurons. The circ-Pank1 knockdown ameliorated dopaminergic neuron damage and locomotor dysfunction after the treatment with rotenone. We found that circ-Pank1 could adsorb miR-7a-5p and upregulate the expression of α-synuclein (α-syn), which is a molecular hallmark closely related to PD. The inhibition of miR-7a-5p reversed the circ-Pank1 knockdown-induced amelioration of dopaminergic neuron injury. In conclusion, circ-Pank1 is overexpressed in PD and enhances the locomotor dysfunction via the miR-7a-5p/α-syn signaling axis. We revealed the functional role of circRNAs in the progression of PD and provided a potential target for noncoding RNAs in delaying the progression of PD. |
format | Online Article Text |
id | pubmed-9120029 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-91200292022-05-21 circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson’s disease Liu, Qing Li, Qiyao Zhang, Runjiao Wang, Hongfang Li, Yibo Liu, Ziyu Xie, Wenmeng Geng, Dandan Wang, Lei Cell Death Dis Article Circular RNA (circRNA) is a type of non-coding RNA that is widely expressed in mammals. It is highly conserved and abundantly expressed in the brain. Here, we report the regulatory role of circRNA derived from the pantothenate kinase 1 (Pank1) gene (circ-Pank1) in Parkinson’s disease (PD). Circ-Pank1 is highly expressed in the substantia nigra (SN) of PD model mice treated with rotenone and in the MN9D cell model of dopaminergic neurons. The circ-Pank1 knockdown ameliorated dopaminergic neuron damage and locomotor dysfunction after the treatment with rotenone. We found that circ-Pank1 could adsorb miR-7a-5p and upregulate the expression of α-synuclein (α-syn), which is a molecular hallmark closely related to PD. The inhibition of miR-7a-5p reversed the circ-Pank1 knockdown-induced amelioration of dopaminergic neuron injury. In conclusion, circ-Pank1 is overexpressed in PD and enhances the locomotor dysfunction via the miR-7a-5p/α-syn signaling axis. We revealed the functional role of circRNAs in the progression of PD and provided a potential target for noncoding RNAs in delaying the progression of PD. Nature Publishing Group UK 2022-05-19 /pmc/articles/PMC9120029/ /pubmed/35589691 http://dx.doi.org/10.1038/s41419-022-04934-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Liu, Qing Li, Qiyao Zhang, Runjiao Wang, Hongfang Li, Yibo Liu, Ziyu Xie, Wenmeng Geng, Dandan Wang, Lei circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson’s disease |
title | circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson’s disease |
title_full | circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson’s disease |
title_fullStr | circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson’s disease |
title_full_unstemmed | circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson’s disease |
title_short | circ-Pank1 promotes dopaminergic neuron neurodegeneration through modulating miR-7a-5p/α-syn pathway in Parkinson’s disease |
title_sort | circ-pank1 promotes dopaminergic neuron neurodegeneration through modulating mir-7a-5p/α-syn pathway in parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120029/ https://www.ncbi.nlm.nih.gov/pubmed/35589691 http://dx.doi.org/10.1038/s41419-022-04934-2 |
work_keys_str_mv | AT liuqing circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease AT liqiyao circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease AT zhangrunjiao circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease AT wanghongfang circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease AT liyibo circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease AT liuziyu circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease AT xiewenmeng circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease AT gengdandan circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease AT wanglei circpank1promotesdopaminergicneuronneurodegenerationthroughmodulatingmir7a5pasynpathwayinparkinsonsdisease |